(Q33732940)

29 July 2017

1 reference

title

The potential role of rapamycin in pediatric transplantation as observed from adult studies (English)

1 reference

29 July 2017

1 reference

B D Kahan

1

1 reference

29 July 2017

publication date

1 August 1999

1 reference

Pediatric Transplantation

29 July 2017

published in

1 reference

29 July 2017

volume

3

1 reference

29 July 2017

issue

3

1 reference

29 July 2017

page(s)

175-180

1 reference

Rapamycin selectively inhibits interleukin-2 activation of p70 S6 kinase

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00036.X

Immunosuppressive effects and safety of a sirolimus/cyclosporine combination regimen for renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00036.X

Sirolimus: a new agent for clinical renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00036.X

Sirolimus (rapamycin)-based therapy in human renal transplantation: similar efficacy and different toxicity compared with cyclosporine. Sirolimus European Renal Transplant Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00036.X

Control of p70 s6 kinase by kinase activity of FRAP in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00036.X

A mammalian protein targeted by G1-arresting rapamycin-receptor complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00036.X

Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00036.X

cAMP- and rapamycin-sensitive regulation of the association of eukaryotic initiation factor 4E and the translational regulator PHAS-I in aortic smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00036.X

A regulatory role for cAMP in phosphatidylinositol 3-kinase/p70 ribosomal S6 kinase-mediated DNA synthesis in platelet-derived-growth-factor-stimulated bovine airway smooth-muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00036.X

Effects of cyclosporin, FK506, and rapamycin on graft-vessel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00036.X

Variable oral absorption of cyclosporine. A biopharmaceutical risk factor for chronic renal allograft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00036.X

Preclinical evaluation of a new potent immunosuppressive agent, rapamycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00036.X

7 January 2021

The side effect profile of sirolimus: a phase I study in quiescent cyclosporine-prednisone-treated renal transplant patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00036.X

7 January 2021

Challenges in cyclosporine therapy: the role of therapeutic monitoring by area under the curve monitoring.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00036.X

7 January 2021

The influence of pretransplant lipoprotein abnormalities on the early results of renal transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00036.X

7 January 2021

PDGF-AA, a potent mitogen for cardiac fibroblasts from adult rats

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00036.X

7 January 2021

Insulin signaling and its regulation of system A amino acid uptake in cultured rat vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00036.X

7 January 2021

Treatment with rapamycin and mycophenolic acid reduces arterial intimal thickening produced by mechanical injury and allows endothelial replacement.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00036.X

7 January 2021

Rapamycin for immunosuppression in organ allografting.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00036.X

7 January 2021

Factors contributing to the development of chronic rejection in heterotopic rat heart transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00036.X

7 January 2021

Risk factors for chronic rejection in renal allograft recipients.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00036.X

7 January 2021

Evidence that rapamycin rescue therapy delays rejection of major (MHC) plus minor (non-MHC) histoincompatible heart allografts in rats

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00036.X

7 January 2021

10.1034/J.1399-3046.1999.00036.X

Identifiers

DOI

1 reference

29 July 2017

1 reference